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Abstract This study presents a selective method of
isolation of zearalenone (ZON) and its metabolite, α-
zearalenol (α-ZOL), in neoplastically changed human
tissue by accelerated solvent and ultrasonic extractions
using a mixture of acetonitrile/water (84/16% v/v) as the
extraction solvent. Extraction effectiveness was deter-
mined through the selection of parameters (composition
of the solvent mixture, temperature, pressure, number of
cycles) with tissue contamination at the level of nanograms
per gram. The produced acetonitrile/water extracts were
purified, and analytes were enriched in columns packed with
homemade molecularly imprinted polymers. Purified extracts
were determined by liquid chromatography (LC) coupled with
different detection systems (diode array detection - DAD and
mass spectrometry - MS) involving the Ascentis RP-Amide as
a stationary phase and gradient elution. The combination of
UE-MISPE-LC (ultrasonic extraction - molecularly imprinted
solid-phase extraction - liquid chromatography) produced
high (R≈95–98%) and repeatable (RSD<3%) recovery
values for ZON and α-ZOL.
Keywords Zearalenone .α-Zearalenol . Molecularly
imprinted polymers . Liquid chromatography. DAD/MS .
Endometrial cancer
Introduction
Zearalenone (ZON), also referred to as F-2 toxin, is an
estrogenic mycotoxin produced by selected fungi of the
genus Fusarium: Fusarium graminearum, Fusarium cul-
morum, Fusarium cerealis, Fusarium equiseti, Fusarium
crookwellense, and Fusarium semitectum (mostly F. grami-
nearum and F. culmorum) [1]. ZON and its metabolites
have a toxic effect because their structure and shape
resembles that of natural estrogens, such as estradiol,
estrone, and estriol [2–5].
ZON metabolism has been studied in pigs [6]. Research
results have shown that, in pigs and, probably in humans,
ZON is rapidly absorbed after the ingestion of contaminated
food, and it is very quickly metabolized in the intestines and
liver [6–8]. ZON is reduced, mainly to α-ZOL, and in
smaller quantities to β-ZOL (Fig. 1), which are then
decomposed to α-ZAL and β-ZAL [5, 7, 9]. Hydroxysteroid
dehydrogenase (HSD) plays a key role in those trans-
formations. Since ZON has a very similar structure to
estradiol, it becomes a substrate for 3α-HSD and 3β-HSD
[10]. ZON is metabolized to α-ZOL with the involvement of
3α-HSD and to β-ZOL with the involvement of 3β-HSD
[11]. Excessive levels of ZON and its metabolites are
excreted from the body with urine and bile. Following the
ingestion of a single ZON dose of 100 mg, its concentrations
in urine decreased over time as an indication of ZON's
metabolism. Zearalenone and its metabolites demonstrate
genotoxic activity which results in DNA replication dis-
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ruptions, chromosomal aberrations (changes in the structure
or number of chromosomes), changes in sister chromatids
(disruptions during the meiotic or mitotic division of
separating chromatids that give rise to new chromosomes),
induction of DNA fragmentation (deletion, inversion, dupli-
cation, translocation), cell cycle pause, inhibition of protein
and DNA synthesis, and apoptosis [3, 11–17]. Every change
in the DNA nucleotide sequence leads to mutations.
Although some mutations are symptom-free, they exert an
effect on the body. There exists a close correlation between
mutations and the formation of neoplastic cells. Many
mutagens are carcinogens, i.e., factors that contribute to the
formation of neoplasms [3, 17–19].
Analyses of toxic and harmful compounds occurring at low
concentrations have prompted the search for selective methods
of isolating and enriching those compounds from biological
matrices, including highly complex matrices such as blood,
tissue, and urine at low concentration levels [15, 20]. An
alternative to traditional extraction methods could be posed by
solid-phase extraction using selective adsorbents, such as
molecularly imprinted polymers (MIP) for isolating and
enriching zearalenone and its metabolites, in particular, from
complex biological samples. MIPs are increasingly often used
as packing for chromatography columns and adsorbents in
solid-phase extractions as a relatively cheaper (in comparison
with immunosorbents, for example) option that result in
higher selectivity than traditional packing [21–27].
This paper investigates the use of molecularly imprinted
polymers in purifying extracts and isolating zearalenone and
its metabolite, α-zearalenol (α-ZOL), in neoplastic endome-
trial tissue. Scant sources suggest that this mycotoxin may be
one of the causes of endometrial cancer. The experimental
results of Urraca et al. [21–23] were used to produce a series
of polymers with an imprinted cyclododecyl 2,4-dihydrox-
ybenzoate (CDHB) particle, a structural analog of ZON.
The physical and chemical characteristics of the synthe-
sized CDHB and molecularly imprinted polymers (nuclear
magnetic resonance - NMR, infrared spectroscopy- IR,
scanning electron micrographs (SEM)) were determined.
ZON and α-ZOL were extracted from tissue by accelerated
solvent extraction (ASE) and ultrasonic extraction (UE).
The obtained extracts were purified by molecularly
imprinted solid-phase extraction (MISPE). This type of
MIP-CDHB was used for isolating zearalenone and its
metabolite and for purifying acetonitrile/water extractions
from neoplastic tissue for the first time. Samples were
analyzed by liquid chromatography with diode array
detection (DAD) and mass spectrometry (MS) with an
atmospheric-pressure chemical ionization (APCI) interface.
Materials and methods
Reagents
ZON, α-ZOL, 2,2'-azobisisobutyronitrile, 1-allyl-piperazine
(1-ALPP) (96%), trimethylolpropane trimethacrylate (TRIM;
techn.), cyclododecanol, 1,1’-carbonyldiimidazole (≥90%),
dimethyl fumarate, 2,4-dihydroxybenzoate acid (97%), 1,8-
diazabicyclo[5.4.0]undec-7-ene were purchased from Fluka
(Sigma-Aldrich Chemie, Steinheim, Germany). For MISPE
and chromatographic analyses, organic solvents of high
performance liquid chromatography (HPLC) grade pur-
chased from Baker (Groß-Gerau, Germany) and deionized
water (Mili-Q, Millipore, El Paso, TX, USA) were
employed. Aluminum oxide (150 mesh) and silica gel
(230–400 mesh) for CDHB purification was supplied by
Merck (Darmstadt, Germany). Anhydrous sodium sulfate
(POCh, Gliwice, Poland) was the drying agent.
Working solutions were prepared by weighing 1.09 mg
zearalenone and 1.10 mg α-zearalenol and dissolving them
in acetonitrile in 10 ml volumetric flasks. The produced
solutions had the concentration of 109.0 μg/ml zearalenone
and 110.0 μg/ml α-zearalenol. Solutions of lower concen-
trations were produced by diluting the working solutions to
obtain concentrations of 0.01 to 3 μg/ml in the mobile phase.
Fig. 1 Sample metabolic path-
way of zearalenone [7]
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Equipment
Liquid chromatography analyses were carried out using an
Agilent Technologies 1100 chromatograph with an Ascentis
RP-Amide column (Supelco, USA; 250×4.6 mm ID, 5 μm
particle size) equipped with a DAD, mass spectrometer (MSD
Trap VL Agilent), and an autosampler. Data acquisition and
quantification were conducted using Agilent ChemStation
software. The column was kept in an oven (Gynkotek,
Germering, Germany) at a temperature of 21.0 °C±0.1.
Chromatographic separations were performed using a gradi-
ent elution with acetonitrile (A) and water (B)—0–5min, 50%
A; 5–25 min 50–100% A; 35 min 100% A; 35–45 min 100–
50% A; and 55 min 50% A. The flow rate was 1 ml/min;
column temperature was kept at 21 °C, and analytical
wavelength was set at λ=270 nm. Injection volume was
Fig. 2 1H NMR (a) and 13C NMR (b) spectra for cyclododecyl 2,4-dihydroxybenzoate
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10 μl. The mass spectrometer was equipped with an APCI
source. The following APCI conditions were applied:
ionizing gas (nitrogen), 60 psi; flow, 7.5 ml/min; auxiliary
gas (helium), 10 psi; ion source temperature, 278 °C; gas
Fig. 4 Scanning electron micro-
graphs of non-imprinted (a) and
imprinted (b) polymer
(MIP-CDHB)
Fig. 3 Structure of 1-ALPP and
CDHB molecules and the prob-
able location of hydrogen bonds
between the template and
monomer molecules
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drying temperature, 320 °C; and corona current, 3,000 nA.
The mass spectra of the analyzed xenoestrogens were within
the scanning range of 300–350 m/z in the negative ionization
option at capillary voltage 4.0 V.
1H and 13C NMR spectra were recorded with Bruker
300 MSL (Rhenstteten, Germany) spectrometer at 300 and
75 MHz, respectively. Infrared spectroscopy results were
obtained on Perkin-Elmer 1800 (Norwalk, CT, USA)
infrared spectrophotometer. Melting points were obtained
with a Fischer Johns melting point apparatus. The porosity
and surface area of the developed micro/nanospheres and
bulk polymers were determined by nitrogen adsorption/
desorption analysis using a nitrogen surface area analyzer
(ASAP 2012, Micromeritics Instrument Corp., USA). SEM
results were obtained using Leo 1430 VP apparatus (Leo,
Electronenmikroskopie, GmbH, Oberkochen, Germany).
Solid-phase extraction was performed using a 12-port
vacuum manifold supplied by Mallinckrodt Baker
(Deventer, The Netherlands). MISPE columns were prepared
using solid-phase extraction (SPE) glass columns (volume
of 1 ml) equipped with porous polytetrafluoroethylene
(PTFE) disks (Mallinckrodt Baker) at the top and at the
bottom of the polymer bed. Soxhlet extractions were carried
out using an extractor supplied by Agat (Szczecin, Poland).
Synthesis of cyclododecyl 2,4-dihydroxybenzoate
The synthesis of the ZON-mimic template, cyclododecanyl-
2,4-dihydroxybenzoate, has been described by Urraca et al.
[21, 23]. For the purpose of obtaining pure cyclododecyl
2,4-dihydroxybenzoate, its synthesis was modified by
annealing silica gel at 120 °C for 24 h until the purification
stage. Elution was carried out using an n-hexane: octane
ethyl mixture (60:40% v/v). The product was crystallized
and dried in a vacuum drier, producing a white solid
substance with melting point in the range of 57.5 °C to 61 °C.
Nuclear magnetic resonance was performed for 1H and13C to
verify the product's structure. Deuterated chloroform was
applied as the solvent, and trimethylsilane was the reference
standard (Fig. 2a, b).
The IR spectrum was obtained by preparing a KBr sample.
It was used to determine vibrational frequency ν: 3,487;
3,161; 3,933; 1,656; 1,469; 1,253; 852; and 779 cm−1.
Polymer synthesis
Two types of polymers were prepared simultaneously. In the
first polymer, 1 mmol cyclododecyl 2,4-dihydroxybenzoate
(MIP) was used as the template, while the second polymer
was prepared without a template to produce a non-imprint
polymer (NIP). The initiator in the synthesis of both
polymers was 2,2'-azobis(isobutynitrile) (0.47 mmol). 1-
Allyl-piperazine (4 mmol) was the functional monometer;
TRIM (20 mmol) was the cross-linking monomer, and
acetonitrile was the pore-forming solvent [22, 23]. The
monomer to pore-forming solvent volume ratio was 40:60.
Polymerization was carried out twice in tight vials of 15
and 2 ml. Polymerization mixtures were degassed in an
ultrasound bath and rinsed with nitrogen for 30 min. Vials
were placed in a chamber with a thermostat-controlled
water bath (4 °C) and a UV lamp (λ=365 nm). Photo-
polymerization was carried out for 1.5 h. The probable
location of hydrogen bonds between a CDHB molecule and
1-ALPP molecules is shown in Fig. 3. Polymers were
disintegrated; the template and non-reacted substrates were
extracted with a methanol and acetic acid mixture (96:4%
v/v) in a Soxhlet apparatus over 24 h, because ASE did not
fully remove the template. Non-imprinted polymers were
prepared following the same procedure but in the absence
of template molecule. Structural variations in the surface
morphology and internal structure of the both MIP and NIP
polymer particles resulting were studied by the SEM











MeOH 42 2 110
2 ACN/H2O 84:16
3 ACN/MeOH 84:16





7 ACN/MeOH 84:16 46
8 ACN/H2O 84:16 46
9 Poultry liver ACN/H2O 84:16 52 150
10 ACN/H2O 84:16 64 200
11 Chloroform 43 110
12 ACN 42 2 110
Table 1 Selection of parameters
for ASE isolation of ZON and
its metabolite
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microscope (Fig. 4). The SEM microscopic technique
confirmed that the application of acetonitrile gave rise to
a higher number of specific interactions between CDHB
template and monomers (1-ALPP), resulting in compact
and more porous morphology of the imprinted polymers.
CDHB binding with 1-ALPP during MIP synthesis pro-
duced larger globules and pores in comparison with NIP
molecular imprinting without template. The non-imprinted
polymer had very small surface globules.
The polymer was dried in a vacuum drier at 50 °C for 24 h,
producing polymers with a specific surface area of 248 m2/g
and a pore volume of 0.46 cm3/g. The dried product was
disintegrated in a mortar and fractioned with the use of mesh
sieves. The obtained fractions had grain size of 45 to 63 μm,
and they were used to fill SPE columns.
Sample preparation
Samples of uterus tissue were collected from seven women
with endometrial cancer aged 66–76 years during a surgical
procedure. Directly after collection, samples were placed in a
dark container and frozen in liquid nitrogen. In view of the
small quantity and weight of the collected samples, veal and
poultry muscle tissue and poultry liver, whose consistency
was most similar to neoplastic tissue, were used to investigate
extraction and purification effectiveness. Animal tissue
samples were freeze-stored. Frozen animal tissue was
disintegrated and analytical samples of 0.5, 1, 1.5, and 2 g
were prepared. Tissue was contaminated with 100 μl standard
solution of zearalenone and α-zearalenol, each with the
estimated concentration of 10 μg/ml. They were subjected to
UE and ASE by applying different extraction conditions,
solvents, and solvent combinations (Tables 1 and 2).
In the ultrasonic extraction, each sample was twice
extracted using a mixture of acetonitrile (ACN)/H2O
(84:16% v/v), ACN/MeOH (50:50% v/v), ACN/H2O
(50:50% v/v), ACN/MeOH (84:16% v/v), and MeOH/H2O
(80:20% v/v) of 15 ml each. When 15 ml of the solvent
mixture was added, samples were ultrasonically homoge-
nized (5 min, five cycles, 100% power). The supernatant
was centrifuged for 12 min (3,500 rpm).
In ASE (extractor ASE 100, Dionex), each sample was
extracted with different solvents and temperatures (Table 1)
Solvent combination Composition, % v/v α-ZOL ZON
Recovery, % RSDa, % Recovery, % RSDa, %
ACN/H2O 50:50 90.5 2.0 85.3 0.3
ACN/H2O 84:16 97.9 1.6 95.4 1.8
MeOH/H2O 80:20 89.0 0.2 82.5 1.2
ACN/MeOH 50:50 88.7 0.8 91.3 0.1
ACN/MeOH 84:16 92.7 2.1 94.9 1.8
Table 2 Recovery of ZON and
α-ZOL isolated from animal
liver by UE and MIP-CDHB
purification
a RSD, standard deviation (n=4)
Table 3 Results of extractions performed in the ASE apparatus after
MISPE clean-up and preconcentration
No.a Recovery (±RSD), %
ZON α-ZOL
1 19.8 (±3.2) 22.4 (±2.4)
2 61.1 (±1.7) 61.5 (±1.3)
3 60.6 (±2.5) 65.3 (±1.7)
4 69.0 (±1.1) 63.3 (±0.8)
5 79.5 (±0.8) 79.9 (±1.4)
6 69.3 (±1.6) 62.7 (±1.3)
7 70.0 (±0.5) 76.9 (±1.0)
8 70.9 (±1.2) 71.1 (±2.6)
9 79.5 (±1.0) 80.7 (±1.1)
10 89.8 (±0.6) 90.1 (±0.9)
11 52.1 (±2.9) 53.4 (±2.3)
12 28.4 (±3.1) 37.6 (±2.8)
a Number compliant with sample number in Table 1













50 49.4 2.0 59.3 1.6
100 60.7 1.8 66.7 2.1
150 68.9 1.7 80.2 2.2
200 97.9 0.9 95.4 1.4
250 97.2 2.1 95.0 1.9
Solvent: ACN/MeOH 84:16
50 41.5 1.7 42.1 2.3
100 51.5 0.9 57.0 1.4
150 65.5 1.6 68.7 2.0
200 92.7 2.1 94.9 1.8
250 92.1 2.3 93.9 2.0
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under pressure of 1,500 psi. A total of five static cycles
were used at 5 min per cycle, with a final flush of solvent
equal to 75% of the cell volume (approx. 11 mL).
UE- and ASE-derived extracts were evaporated to 2 ml
and diluted with water at the 1:5 ratio. The filtered
supernatant was transferred to MIP-CDHB columns condi-
tioned with 5 ml methanol and 5 ml redistilled water. After
application, the polymer was rinsed with 5 ml redistilled
water. The sorbent was dried, and the adsorbed analytes
were eluted with the solvent.
Results and discussion
Optimization of the ASE and UE method for ZON
and α-ZOL
Due to the absence of documented experiments aiming to
isolate selected analytes from human tissue and very few
studies investigating animal tissue, mixtures of solvents
with various compositions were used as extractants for ASE
(Table 1) and UE (Table 2). In view of the complexity of
biological matrices, the isolation procedure and the sample
purification process required a solvent capable of removing
proteins and fats.
The recovery values for both analytes after UE-MIP-
CDHB with the use of various solvent combinations
(methanol/water, acetonitrile/water) and different volume
ratios were within the range of 82.5–97.9%. The best
results were noted for the ACN/H2O mixture at the
volume ratio of 84:16% v/v where α-ZOL recovery
reached 97.9% and ZON recovery, –95.4%. Low standard
deviation values of 0.2–2.1% testify to the high repeat-
ability of isolation and purification of tissue supernatants
with the use of CDHB-imprinted polymers which are
selective sorbents.
Tissue supernatants produced with the use of solvents
specified in Table 2 were deproteinized and degreased with
hexane. Low recovery values were obtained for both
compounds (ZON and α-ZOL) at 5.49%±2.6% and
4.94%±2.2%, respectively. Excessive acetonitrile concen-
trations in the sample applied to fill the column lowered the
analyte's reaction with the polymer. For this reason,
acetonitrile/water extracts (84:16% v/v) from acetonitrile/
water extract tissue (84:16% v/v) were diluted with water at
the 1:5 ratio without hexane degreasing, and they were
applied to the conditioned MIP-CDHB polymer bed.
Recovery reached 95–97%, indicating that sample depro-
teinization and degreasing were redundant.
Similar results were noted in accelerated solvent extraction
(Table 3). The recovery values reported for extracts with the
use of the 84:16% v/v ACN/water mixture were the highest for
poultry liver and poultry muscle tissue (62 - 90%). Similarly
to temperature growth, an increase in the number of extraction
cycles contributes to higher recovery values (5 cycles, 200 °C,
64 ml). The highest recovery values for zearalenone (89.8%)
and for α-zearalenol (90.1%) were reported for four extraction
cycles with a combination of ACN/H2O (84:16% v/v) solvents
at a temperature of 200 °C. The use of pure solvents, i.e.,
acetonitrile, methanol, and chloroform, did not bring satisfac-
tory results. Recovery values were significantly lower (more
than 50%) compared with those obtained with the use of the
above solvent mixtures (Table 3).
When non-imprint polymers (NIP) were used, recovery
values for both ZON and α-ZOL dropped by 40% in
comparison with MIP-CDHB. The repeated use of the NIP
column led to an increase in the intensity of peaks
generated by the coexisting compounds. An increase in
the quantity of the above polymer had no significant effect
on extract purification.
The effect of polymer quantity on recovery values
In both extraction methods (UE and ASE) used to isolate
ZON and α-ZOL, the most satisfactory results were
reported in respect of ACN/H2O (84:16% v/v) and ACN/
MeOH (84:16% v/v), and the above mixtures were taken
into account during the selection of extraction parameters
Table 5 Limit of detection and quantification obtained for ZON and
α-ZOL analysis in tissue samples (animal liver) using UE-MISPE and
LC-DAD analysis
Compound LOD, ng/g SD LOQ, ng/g SD
ZEA 8.10 0.27 24.30 0.10
α-ZOL 14.02 0.28 42.06 0.14
LOD limit of detection, LOQ limit of quantification
Spiked level, μg/g Recovery of ZON, % RSD, % Recovery of α-ZOL, % RSD, %
0.05 98.4 3.6 96.9 4.1
0.10 98.1 1.7 95.8 1.8
0.25 97.9 1.5 96.2 1.4
0.50 96.5 2.5 93.8 2.4
2.00 94.6 3.1 92.2 3.5
Table 6 Extraction recoveries
(and RSDs) obtained from blank
tissue spiked (animal
liver) at different concentration
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in the MISPE analysis. To verify adsorption and desorp-
tion effectiveness, glass SPE columns were packed with
the same polymer in increasing quantities from 50 to
250 mg. Tissue extracts containing zearalenone and α-
zearalenol in concentrations of 109 and 110 ng/g,
respectively, were applied to each column. The results
are presented in Table 4.
For the purpose of verifying the effectiveness of
zearalenone and α-zearalenol desorption with MIP-
CDHB, various volumes of acetonitrile were applied as
the solvent. The highest recovery values were reported for
4 ml, reaching 97.9% for zearalenone (±0.8%) and 95.4%
for α-zearalenol (±1.4%). Standard deviation was below
1.5%, and the above quantity was regarded as optimal for
effective desorption. The highest recovery values in excess
of 90% were noted in columns packed with 200 and
250 mg MID-CDHB for both solvent combinations.
In view of repeatable (RSD below 2%) and high
recovery values, ZON and α-ZOL were extracted from
neoplastic tissue by the ultrasound-assisted method with the
involvement of ACN/H2O (84:16 % v/v) and purified using
200 mg MIP-CDHB.
Performance of the analytical method
The applied method was validated based on the follow-
ing parameters: linearity, selectivity, precision (repeatabil-
ity), measurement uncertainty, and accuracy. Calibration
curves were determined for the tissue extract (UE-
MISPE), which were linear in the range of concentra-
tions from 0.054 to 10.9 μg/ml for ZON (y=43.252x+
1.3316) and 0.055 to 11.0 μg/ml for α-ZOL (y=34.28x+
0.7014). Linearity was satisfactory in both cases, as
demonstrated by high regression coefficients (r=0.9999
for ZON; r=0.9998 for α-ZOL). The limit of detection for
tissue extracts was computed at the signal-to-noise ratio of
3:1, and the limit of quantification—at the signal-to-noise
ratio of 10:1 (Table 5). The values reported for liquid
chromatography-diode array detection (LC-DAD) are
insignificantly higher in comparison with fluorescent
detection [21, 23], therefore mass spectrometry was used
to confirm analyte identity.
Coefficients of variation (RSD, %) were used to
determine assay precision. RDS values, expressed as the
percentage arithmetic mean (Table 6), were below 4.1% and
can be considered satisfactory.









1 75 Endometrial cancer, grade III; histopathological examination: ovarian
adenocarcinoma
0.7831 0.1474
2 66 Endometrial cancer, grade I; histopathological examination: endometrial
adenocarcinoma
0.4501 –
3 71 Endometrial cancer, grade 0; histopathological examination: complex
mucosal hyperplasia
0.1301 –
4 70 Endometrial cancer, grade III; histopathological examination: uterine
sarcoma with parametrial infiltration
0.9644 –
5 76 Endometrial cancer, grade 0; histopathological examination: complex
mucosal hyperplasia
1.6968 0.2865
6 68 Endometrial cancer, grade III; histopathological examination:
undifferentiated serous carcinoma
0.3188 –
7 66 Endometrial cancer, grade I; histopathological examination: endometrial
adenocarcinoma
0.9477 0.1384
Fig 5 Chromatograms of extracts of neoplastically changed tissue
samples from the uterine body of patients no. 5 (a) and no. 7 (b)
2076 R. Gadzała-Kopciuch et al.
Application of the optimized UE-MISPE method for ZON
and α-ZOL extraction
The results of the analysis indicate that the neoplastically
changed tissue samples collected from all patients contained
zearalenone's estrogenic metabolite, α-zearalenol, which
bears a structural resemblance to natural estrogen, 17-β
estradiol, and imitates its activity. Trace quantities of
zearalenone were found in three samples. Zearalenone was
not determined in the remaining four samples. All tissue
samples contained various quantities of α-zearalenol in the
range of 0.1–1.7 μg/g tissue (Table 7, Fig. 5).
No correlations were determined between the α-
zearalenol content of the examined tissue and the clinical
grade of cancer. Tumor consistency and the quantity of α-
zearalenol were correlated (the more compact the tissue, the
smaller quantity of the metabolite was found).
The presence of α-zearalenol and zearalenone in tissue
affected by endometrial cancer was confirmed by the MS in
the negative ionization module (Fig. 6). The presence of α-
zearalenol and zearalenone in neoplastically changed tissue
from the tissue corpus of the uterus was confirmed by ions
with m/z ratios of 317.1 and 319.0, respectively.
Conclusions
Highly efficient molecularly imprinted polymers (MIP-
CDHB) may be used as sorbents in solid-phase extraction
for purification extracts of tissue and preconcentration ZON
and α-ZOL. The studied MIPs are characterized by high
selectivity, and they shorten sample preparation time—the
results of this experiment have shown that hexane depro-
teinization and degreasing of supernatants were redundant.
The presence of α-zearalenol was determined in all
uterus samples, while zearalenone was found in only three
samples. No correlations were determined between the α-
zearalenol content of the studied tissue and the clinical
stage of cancer. Tumor consistency and the quantity of α-
zearalenol were, however, correlated (the more compact the
tissue, the smaller the quantity of the metabolite).
The results of this study indicate that in contrast to affinity
adsorbents, molecularly imprinted polymers are suitable for
purifying samples from the water-organic phase.
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